Form 4: Nutex Health CEO Thomas Vo Adjusts Holdings

Nutex Health Inc. CEO Thomas T. Vo reported a transaction involving common stock and restricted stock units, adjusting his beneficial ownership.

Summary

• Thomas T. Vo, CEO and Director of Nutex Health Inc., filed a Form 4 reporting changes in his beneficial ownership of company stock.
• The filing details the issuance of 184,071 shares of common stock on April 9, 2026, related to obligations for two under-construction hospitals.
• These shares were issued in a private transaction and are linked to a merger agreement from November 23, 2021.
• Vo's indirect beneficial ownership of common stock following this transaction is 2,027,267 shares, held through Micro Hospital Holdings LLC.
• Additionally, the filing corrects the number of restricted stock units (RSUs) beneficially owned, now reported as 16,507.
• This correction pertains to an RSU grant dated March 10, 2026, with a vesting period from March 1, 2026, to March 1, 2029.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily consisting of routine disclosures of stock transactions and corrections to prior filings, with no immediate positive or negative financial implications evident.

Positives

• The issuance of shares related to hospital construction indicates progress on strategic growth initiatives.
• The correction of RSU numbers suggests diligent internal accounting and reporting processes.
• Thomas T. Vo's continued direct and indirect ownership demonstrates ongoing commitment to the company.

Negatives

• The filing does not contain any negative financial or operational information.

Risks

• The underlying merger agreement and related proxy statements referenced in the filing may contain further details on potential risks associated with the hospital development projects.
• The reliance on indirect beneficial ownership through Micro Hospital Holdings LLC could introduce complexities in understanding ultimate control and decision-making.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. However, the issuance of shares for hospital construction implies ongoing development and potential future revenue streams from these facilities.

Management Comments

• The filing is a statement of changes in beneficial ownership and does not contain direct management commentary.
• Explanations reference prior SEC filings for details on the merger agreement and RSU grants.

Industry Context

StockSavvy.ai notes that Form 4 filings by key executives like CEOs and Directors are routine disclosures of stock transactions. For Nutex Health, a company focused on micro-hospitals and surgical centers, such filings often relate to compensation structures (like RSUs) and strategic investments or obligations tied to facility development.

Related Party Transactions

• The issuance of 184,071 shares of common stock is related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC, indicating a transaction involving entities associated with the reporting person.

Stakeholder Impact

• Shareholders: The adjustment in beneficial ownership and the issuance of shares for hospital development may signal continued investment in growth, potentially impacting long-term shareholder value.
• Management: The RSU correction highlights the importance of accurate reporting for executive compensation and equity holdings.
• Creditors/Suppliers: Progress on new hospital facilities could imply future business opportunities or increased operational scale.

Next Steps

• Monitoring the progress and operationalization of the two under-construction hospitals.
• Tracking future SEC filings for further updates on Vo's beneficial ownership and company performance.

Key Dates

Keywords

Nutex Health, NUTX, Form 4, SEC Filing, Thomas T. Vo, CEO, Director, Common Stock, Restricted Stock Units, Beneficial Ownership, Hospital Development, Merger Agreement